Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Waters

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|November 27, 2001
Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancerI Chau, A Webb, D Cunningham, et al.
British Journal of Cancer|October 27, 2004
Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinomaJ S Waters, C Moss, L Pyle, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1991
The measurement of complement fixation by autoantibodies directed against thyroid membrane antigensA B Parkes, S Williams, R D Howells, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphomaJ S Waters, A Webb, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinomaL Assersohn, G Brown, D Cunningham, et al.
British Journal of Cancer|May 13, 2004
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?P J Ross, S Ashley, A Norton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagusJ S Waters, D Tait, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancerT Meyer, M E Caplin, D H Palmer, et al.
British Journal of Cancer|September 15, 2004
Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapyI Chau, A R Norman, D Cunningham, et al.
British Journal of Cancer|July 2, 1999
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trialJ S Waters, A Norman, D Cunningham, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|November 27, 2001
Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancerI Chau, A Webb, D Cunningham, et al.
British Journal of Cancer|October 27, 2004
Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinomaJ S Waters, C Moss, L Pyle, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1991
The measurement of complement fixation by autoantibodies directed against thyroid membrane antigensA B Parkes, S Williams, R D Howells, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphomaJ S Waters, A Webb, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinomaL Assersohn, G Brown, D Cunningham, et al.
British Journal of Cancer|May 13, 2004
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?P J Ross, S Ashley, A Norton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagusJ S Waters, D Tait, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancerT Meyer, M E Caplin, D H Palmer, et al.
British Journal of Cancer|September 15, 2004
Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapyI Chau, A R Norman, D Cunningham, et al.
British Journal of Cancer|July 2, 1999
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trialJ S Waters, A Norman, D Cunningham, et al.
Pageof 3